Latest News: At 9.4% CAGR, Global Point-of-care testing (POCT) Market will reach 36200 Mn US$ by 2025: Roche, Abbott

The objectives of this study are to define, segment, and project the size of the Point-of-care testing (POCT) market based on company, product type, end-user and key regions.

Point-of-care testing (POCT) is a medical testing that can be done at or near a point of care or patient care. It is also known as bedside testing and is carried out by trained healthcare professionals. These tests primarily involve IVD tests that can be performed near the patient. There are test systems are used for detecting disease-causing pathogens and abnormal concentrations of contents in samples such as blood, urine etc.

Ask for Free Sample copy of this report at https://inforgrowth.com/sample-request/1205748/global-point-of-care-testing-poct-market-insig

These devices are used for the immediate diagnosis of disease indications for the early detection and treatment of the disease. Many point-of-care tests systems are available in easy-to-use membrane-based test strips. In the rheumatology diagnostics test, a new test is developed in which only a single drop of urine, blood, or saliva is required, and the physician or surgeon can interpret the information about the disease condition.

The main benefits of Point-of-care testing (POCT) are convenience and rapid diagnosis. This boosts the likelihood that the care team and physician will obtain the results faster, allowing clinicians to support on time monitoring, diagnosis, and treatment of patients.

The increasing usage of home-based monitoring such as glucose monitoring systems for diabetic patients is the key trend that is driving the point-of-care testing market.
North America holds the highest share in the point-of-care test market due to an increase in lifestyle-related diseases in the region.

North America is the largest sales place, with a sales market share nearly 44.02% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 29.45%.

The global Point-of-Care Testing (POCT) market is valued at 17600 million US$ in 2018 and will reach 36200 million US$ by the end of 2025, growing at a CAGR of 9.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Point-of-Care Testing (POCT) market based on company, product type, end user and key regions.

This report studies the global market size of Point-of-care testing (POCT) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Point-of-care testing (POCT) in these regions.

The objectives of this study are to define, segment, and project the size of the Point-of-care testing (POCT) market based on company, product type, end user and key regions.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, ARKRAY, Nova Biomedical, Trividia Health, Quidel, Accriva, OraSure Technologies, Helena Laboratories, A. Menarini Diagnostics, Abaxis (Zoetis), Ortho Clinical Diagnostics, Phamatech, Chembio Diagnostics, Trinity Biotech, ELITech Group, Response Biomedical, Princeton BioMeditech, Alfa Wassermann.

Then Point-of-care testing (POCT) Report provides data breakdown by types like Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Othersand by applications like Clinics, Hospitals, Laboratory, Others.

Order a copy of Point-of-care testing (POCT) Market 2019-2025 Report at https://inforgrowth.com/purchase/1205749/global-point-of-care-testing-poct-market-insights-forecast-to-2025-SingleUser

Regions covered in this report are North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Malaysia, Philippines, Thailand, Vietnam, Europe, Germany, France, UK, Italy, Spain, Russia, Central & South America, Brazil, Rest of Central & South America, Middle East & Africa, GCC Countries, Turkey, Egypt, South Africa.

Major Points from Table of Contents
1 Study Coverage
2 Executive Summary
3 Breakdown Data by Manufacturers
4 Breakdown Data by Product
5 Breakdown Data by End User
6 North America
7 Europe
8 Asia Pacific
9 Central & South America
10 Middle East and Africa
11 Company Profiles
12 Future Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
14 Value Chain and Sales Channels Analysis
15 Research Findings and Conclusion
And More

Ask your custom requirements or queries about this report at https://inforgrowth.com/customization/1205748/global-point-of-care-testing-poct-market-insig

Contact Info:
Name: Rohan
Email: Send Email
Organization: InForGrowth
Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA
Phone: +1-909-329-2808
Website: http://www.inforgrowth.com

Release ID: 492456